• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

确定甲状旁腺切除术治疗症状性甲状旁腺功能亢进后影响骨密度的独立因素。

Identification of independent factors affecting bone mineral density after successful parathyroidectomy for symptomatic hyperparathyroidism.

机构信息

Department of Orthopedic Trauma, Peking University Fourth School of Clinical Medicine, Beijing Jishuitan Hospital, Beijing, 100035, China.

Department of General Surgery, Peking University Fourth School of Clinical Medicine, Beijing Jishuitan Hospital, Beijing, 100035, China.

出版信息

BMC Endocr Disord. 2020 Sep 14;20(1):141. doi: 10.1186/s12902-020-00622-4.

DOI:10.1186/s12902-020-00622-4
PMID:32928178
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7490883/
Abstract

BACKGROUND

Studies have shown that the response of bone mineral density (BMD) to parathyroidectomy for symptomatic primary hyperparathyroidism (PHPT) is heterogeneous and difficult to predict. However, the independent factors affecting BMD in PHPT patients after parathyroidectomy remains limited and inconclusive. This study aimed to explore the independent factors affecting BMD changes in symptomatic PHPT patients after parathyroidectomy.

METHODS

This study retrospectively analyzed 105 patients with symptomatic PHPT treated at Beijing Jishuitan Hospital between January 2010 and December 2015. The primary outcome was a > 10% increase in BMD at 3 years after parathyroidectomy compared with the preoperative value, whereas the secondary outcomes were BMD changes at various measurement sites.

RESULTS

A total of 105 patients with a mean age of 46.37 years were included in this study. Univariate logistic regression analysis indicated that hypertension (odds ratio [OR[: 0.032; 95% confidence interval [CI]: 0.001-0.475; P = 0.012), and parathyroid hormone level (OR: 1.006; 95% CI: 1.004-1.009; P = 0.044) were associated with the > 10% BMD increase. However, these results were not significant after adjustments for potential confounders. Moreover, the BMD values at the lumbar spine, femoral neck, femoral trochanter, Ward's triangle, and whole body after parathyroidectomy were significantly greater than those before the operation (P < 0.05).

CONCLUSIONS

This study suggests that patient characteristics were not associated with the > 10% BMD increase. However, the BMD values of the femur and lumbar spine were significantly increased in symptomatic PHPT patients after parathyroidectomy.

摘要

背景

研究表明,甲状旁腺切除术治疗有症状的原发性甲状旁腺功能亢进症(PHPT)后骨密度(BMD)的反应具有异质性,难以预测。然而,甲状旁腺切除术后影响 PHPT 患者 BMD 的独立因素仍然有限且尚无定论。本研究旨在探讨甲状旁腺切除术后有症状的 PHPT 患者 BMD 变化的独立影响因素。

方法

本研究回顾性分析了 2010 年 1 月至 2015 年 12 月在北京积水潭医院接受治疗的 105 例有症状的 PHPT 患者。主要结局是与术前相比,甲状旁腺切除术后 3 年内 BMD 增加超过 10%;次要结局是各个测量部位的 BMD 变化。

结果

本研究共纳入 105 例平均年龄为 46.37 岁的患者。单因素逻辑回归分析表明,高血压(比值比[OR]:0.032;95%置信区间[CI]:0.001-0.475;P=0.012)和甲状旁腺激素水平(OR:1.006;95% CI:1.004-1.009;P=0.044)与>BMD 增加 10%有关。然而,在调整了潜在混杂因素后,这些结果并不显著。此外,甲状旁腺切除术后腰椎、股骨颈、股骨粗隆、Ward 三角和全身的 BMD 值均明显高于术前(P<0.05)。

结论

本研究表明,患者特征与>BMD 增加 10%无关。然而,甲状旁腺切除术后有症状的 PHPT 患者的股骨和腰椎 BMD 值显著增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a59/7490883/e0209a5224ac/12902_2020_622_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a59/7490883/b21148bb8506/12902_2020_622_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a59/7490883/e0209a5224ac/12902_2020_622_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a59/7490883/b21148bb8506/12902_2020_622_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a59/7490883/e0209a5224ac/12902_2020_622_Fig3_HTML.jpg

相似文献

1
Identification of independent factors affecting bone mineral density after successful parathyroidectomy for symptomatic hyperparathyroidism.确定甲状旁腺切除术治疗症状性甲状旁腺功能亢进后影响骨密度的独立因素。
BMC Endocr Disord. 2020 Sep 14;20(1):141. doi: 10.1186/s12902-020-00622-4.
2
Predictors of bone mineral density improvement in patients undergoing parathyroidectomy for primary hyperparathyroidism.原发性甲状旁腺功能亢进症患者接受甲状旁腺切除术后骨矿物质密度改善的预测因素。
World J Surg. 2014 Jun;38(6):1268-73. doi: 10.1007/s00268-014-2555-6.
3
Changes in bone mineral density after parathyroidectomy in patients with moderate to severe primary hyperparathyroidism.甲状旁腺切除术治疗中重度原发性甲状旁腺功能亢进症患者的骨密度变化。
J Int Med Res. 2020 Oct;48(10):300060520964698. doi: 10.1177/0300060520964698.
4
Individual site-specific bone mineral density gain in normocalcemic primary hyperparathyroidism.正常血钙水平的原发性甲状旁腺功能亢进症中特定部位的骨矿物质密度增加情况。
Osteoporos Int. 2014 Jul;25(7):1963-8. doi: 10.1007/s00198-014-2689-2. Epub 2014 Mar 28.
5
The effect of parathyroidectomy on bone mineral density in primary hyperparathyroidism.甲状旁腺切除术对原发性甲状旁腺功能亢进症患者骨密度的影响。
Turk J Med Sci. 2019 Dec 16;49(6):1674-1680. doi: 10.3906/sag-1904-49.
6
Estrogen replacement may be an alternative to parathyroid surgery for the treatment of osteoporosis in elderly postmenopausal women presenting with primary hyperparathyroidism: a preliminary report.对于患有原发性甲状旁腺功能亢进的老年绝经后女性,雌激素替代疗法可能是替代甲状旁腺手术治疗骨质疏松症的一种选择:一项初步报告。
Osteoporos Int. 1996;6(4):329-33. doi: 10.1007/BF01623394.
7
Bone mineral density in menopausal women with primary hyperparathyroidism before and after parathyroidectomy.原发性甲状旁腺功能亢进症绝经后女性甲状旁腺切除术前及术后的骨密度
World J Surg. 2004 Nov;28(11):1148-52. doi: 10.1007/s00268-004-7562-6.
8
Parathyroidectomy Improves Bone Density in Women With Primary Hyperparathyroidism and Preoperative Osteopenia.甲状旁腺切除术可改善原发性甲状旁腺功能亢进伴术前骨质疏松症妇女的骨密度。
J Clin Endocrinol Metab. 2024 May 17;109(6):1494-1504. doi: 10.1210/clinem/dgad718.
9
Preoperative Thoracic Muscle Mass Predicts Bone Density Change After Parathyroidectomy in Primary Hyperparathyroidism.原发性甲状旁腺功能亢进症甲状旁腺切除术后胸肌质量预测骨密度变化。
J Clin Endocrinol Metab. 2022 May 17;107(6):e2474-e2480. doi: 10.1210/clinem/dgac083.
10
Effectiveness of anti-osteoporotic treatment after successful parathyroidectomy for primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial.甲状旁腺切除术治疗原发性甲状旁腺功能亢进症后抗骨质疏松治疗的疗效:一项随机、双盲、安慰剂对照试验。
Langenbecks Arch Surg. 2019 Sep;404(6):681-691. doi: 10.1007/s00423-019-01815-9. Epub 2019 Aug 26.

引用本文的文献

1
Factors influencing bone mineral density in hyperparathyroidism phenotypes: a prospective study.甲状旁腺功能亢进症各表型中影响骨矿物质密度的因素:一项前瞻性研究。
Front Endocrinol (Lausanne). 2025 May 28;16:1562340. doi: 10.3389/fendo.2025.1562340. eCollection 2025.
2
Characteristics, management and outcomes of primary hyperparathyroidism from 2009 to 2021: a single centre report from South Africa.2009 年至 2021 年原发性甲状旁腺功能亢进症的特征、治疗及预后:南非单中心报告。
BMC Endocr Disord. 2024 Apr 25;24(1):53. doi: 10.1186/s12902-024-01583-8.

本文引用的文献

1
Prediction of bone mass changes after successful parathyroidectomy using biochemical markers of bone metabolism in primary hyperparathyroidism: is it clinically useful?使用原发性甲状旁腺功能亢进症骨代谢生化标志物预测成功甲状旁腺切除术后的骨量变化:它在临床上有用吗?
Arch Endocrinol Metab. 2019 Jul 29;63(4):394-401. doi: 10.20945/2359-3997000000154.
2
Bone mineral density changes after parathyroidectomy are dependent on biochemical profile.甲状旁腺切除术后骨密度的变化取决于生化特征。
Surgery. 2019 Jan;165(1):107-113. doi: 10.1016/j.surg.2018.04.065. Epub 2018 Oct 14.
3
Bone Involvement in Primary Hyperparathyroidism and Changes After Parathyroidectomy.
原发性甲状旁腺功能亢进症中的骨骼受累及甲状旁腺切除术后的变化。
Eur Endocrinol. 2014 Feb;10(1):84-87. doi: 10.17925/EE.2014.10.01.84. Epub 2014 Feb 28.
4
Hyperparathyroidism.甲状旁腺功能亢进症。
Lancet. 2018 Jan 13;391(10116):168-178. doi: 10.1016/S0140-6736(17)31430-7. Epub 2017 Sep 17.
5
Effect of Surgery Versus Observation: Skeletal 5-Year Outcomes in a Randomized Trial of Patients With Primary HPT (the SIPH Study).手术与观察对原发性甲状旁腺功能亢进症患者骨骼 5 年结局的影响:一项随机试验(SIPH 研究)。
J Bone Miner Res. 2017 Sep;32(9):1907-1914. doi: 10.1002/jbmr.3177. Epub 2017 Jul 7.
6
Predictors of bone mineral density improvement in patients undergoing parathyroidectomy for primary hyperparathyroidism.原发性甲状旁腺功能亢进症患者接受甲状旁腺切除术后骨矿物质密度改善的预测因素。
World J Surg. 2014 Jun;38(6):1268-73. doi: 10.1007/s00268-014-2555-6.
7
Incidence and prevalence of primary hyperparathyroidism in a racially mixed population.原发性甲状旁腺功能亢进症在不同种族人群中的发病率和患病率。
J Clin Endocrinol Metab. 2013 Mar;98(3):1122-9. doi: 10.1210/jc.2012-4022. Epub 2013 Feb 15.
8
Skeletal effects of primary hyperparathyroidism: bone mineral density and fracture risk.原发性甲状旁腺功能亢进的骨骼影响:骨密度和骨折风险。
J Clin Densitom. 2013 Jan-Mar;16(1):28-32. doi: 10.1016/j.jocd.2012.11.013.
9
Epidemiology of primary hyperparathyroidism in Tayside, Scotland, UK.英国苏格兰泰赛德地区原发性甲状旁腺功能亢进症的流行病学研究
Clin Endocrinol (Oxf). 2009 Oct;71(4):485-93. doi: 10.1111/j.1365-2265.2008.03520.x.
10
Hyperparathyroidism.甲状旁腺功能亢进症。
Lancet. 2009 Jul 11;374(9684):145-58. doi: 10.1016/S0140-6736(09)60507-9.